TWENTY-FIRST CENTURY GROUP, INC.

Lobbying for NRX PHARMACEUTICALS INC (FORMERLY KNOWN AS NEURORX) · Pharmaceutical company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Delaware · House · Senate · $24,000.00 income · posted Oct 19, 2025

Lobbying activity 3

Health Issues

Research and treatment related to suicide prevention for veterans and patients with bipolar depression or PTSD.

Medical/Disease Research/Clinical Labs

Research and treatment related to suicide prevention for veterans and patients with bipolar depression or PTSD.

Veterans

Research and treatment related to suicide prevention for veterans and patients with bipolar depression or PTSD.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.